These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15644001)

  • 1. Living donor and split-liver transplants in hepatitis C recipients: does liver regeneration increase the risk for recurrence?
    Humar A; Horn K; Kalis A; Glessing B; Payne WD; Lake J
    Am J Transplant; 2005 Feb; 5(2):399-405. PubMed ID: 15644001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.
    Humar A; Beissel J; Crotteau S; Kandaswamy R; Lake J; Payne W
    Transplantation; 2008 May; 85(10):1420-4. PubMed ID: 18497681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
    Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
    Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver regeneration after adult living donor and deceased donor split-liver transplants.
    Humar A; Kosari K; Sielaff TD; Glessing B; Gomes M; Dietz C; Rosen G; Lake J; Payne WD
    Liver Transpl; 2004 Mar; 10(3):374-8. PubMed ID: 15004764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do graft type or donor source affect acute rejection rates after liver transplant: a multivariate analysis.
    Nguyen TH; Melancon K; Lake J; Payne W; Humar A
    Clin Transplant; 2008; 22(5):624-9. PubMed ID: 18459996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation.
    Killackey MT; Gondolesi GE; Liu LU; Paramesh AS; Thung SN; Suriawinata A; Nguyen E; Roayaie S; Schwartz ME; Emre S; Schiano TD
    Transplant Proc; 2008 Jun; 40(5):1504-10. PubMed ID: 18589139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of live donor liver transplantation in patients with hepatitic C virus infection: the HCV 3 trial experience.
    Sher L; Jennings L; Rudich S; Alexopoulos SP; Netto G; Teperman L; Kinkhabwala M; Brown RS; Pomfret E; Klintmalm G;
    Clin Transplant; 2012; 26(3):502-9. PubMed ID: 22151078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
    Lawal A; Ghobrial R; Te H; Artinian L; Eastwood D; Schiano TD
    Transplant Proc; 2007 Dec; 39(10):3261-5. PubMed ID: 18089367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in partial liver transplantation: deceased donor split-liver vs. live donor liver transplantation.
    Saidi RF; Jabbour N; Li Y; Shah SA; Bozorgzadeh A
    HPB (Oxford); 2011 Nov; 13(11):797-801. PubMed ID: 21999593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in quality of life (QoL) and other patient-reported outcome measures (PROMs) in living-donor and deceased-donor kidney transplant recipients and those awaiting transplantation in the UK ATTOM programme: a longitudinal cohort questionnaire survey with additional qualitative interviews.
    Gibbons A; Bayfield J; Cinnirella M; Draper H; Johnson RJ; Oniscu GC; Ravanan R; Tomson C; Roderick P; Metcalfe W; Forsythe JLR; Dudley C; Watson CJE; Bradley JA; Bradley C
    BMJ Open; 2021 Apr; 11(4):e047263. PubMed ID: 33853805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
    Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
    Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deceased-donor split-liver transplantation in adult recipients: is the learning curve over?
    Cauley RP; Vakili K; Fullington N; Potanos K; Graham DA; Finkelstein JA; Kim HB
    J Am Coll Surg; 2013 Oct; 217(4):672-684.e1. PubMed ID: 23978530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25 Years of a Standardized Technique for Living Donor Intestinal Transplantation: A Systematic Review.
    Gruessner RWG
    Transplant Proc; 2022 Sep; 54(7):1944-1953. PubMed ID: 35933238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
    Terrault NA; Stravitz RT; Lok AS; Everson GT; Brown RS; Kulik LM; Olthoff KM; Saab S; Adeyi O; Argo CK; Everhart JE; Rodrigo del R;
    Hepatology; 2014 Apr; 59(4):1311-9. PubMed ID: 24677192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus.
    Bozorgzadeh A; Jain A; Ryan C; Ornt D; Zand M; Mantry P; Lansing K; Orloff M
    Transplantation; 2004 Apr; 77(7):1066-70. PubMed ID: 15087773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.